Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 280 entries
Sorted by: Best Match Show Resources per page
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Caimmi D, Baiz N, Tanno LK, Demoly P, Arnavielhe S, Murray R, Bedbrook A, Bergmann KC, De Vries G, Fokkens WJ, Fonseca J, Haahtela T, Keil T, Kuna P, Mullol J, Papadopoulos N, Passalacqua G, Samolinski B, Tomazic PV, Valiulis A, van Eerd M, Wickman M, Annesi-Maesano I, Bousquet J.
PMID: 28886234
Clin Exp Allergy. 2017 Dec;47(12):1526-1533. doi: 10.1111/cea.13025. Epub 2017 Oct 11.

BACKGROUND: Visual Analogue Scale (VAS) is a validated tool to assess control in allergic rhinitis patients.OBJECTIVE: The aim of this study was to validate the use of VAS in the MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) app (Allergy...

Cite
Caimmi D, Baiz N, Tanno LK, et al. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control. Clin Exp Allergy. 2017;47(12):1526-1533doi: 10.1111/cea.13025.
Caimmi, D., Baiz, N., Tanno, L. K., Demoly, P., Arnavielhe, S., Murray, R., Bedbrook, A., Bergmann, K. C., De Vries, G., Fokkens, W. J., Fonseca, J., Haahtela, T., Keil, T., Kuna, P., Mullol, J., Papadopoulos, N., Passalacqua, G., Samolinski, B., Tomazic, P. V., Valiulis, A., van Eerd, M., Wickman, M., Annesi-Maesano, I., Bousquet, J. (2017). Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 47(12), 1526-1533. https://doi.org/10.1111/cea.13025
Caimmi, D, et al. "Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control." Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology vol. 47,12 (2017): 1526-1533. doi: https://doi.org/10.1111/cea.13025
Caimmi D, Baiz N, Tanno LK, Demoly P, Arnavielhe S, Murray R, Bedbrook A, Bergmann KC, De Vries G, Fokkens WJ, Fonseca J, Haahtela T, Keil T, Kuna P, Mullol J, Papadopoulos N, Passalacqua G, Samolinski B, Tomazic PV, Valiulis A, van Eerd M, Wickman M, Annesi-Maesano I, Bousquet J. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control. Clin Exp Allergy. 2017 Dec;47(12):1526-1533. doi: 10.1111/cea.13025. Epub 2017 Oct 11. PMID: 28886234.
Copy Download .nbib Format: NLM
Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America.

Clinical and translational allergy

Torres MJ, Romano A, Celik G, Demoly P, Khan DA, Macy E, Park M, Blumenthal K, Aberer W, Castells M, Barbaud A, Mayorga C, Bonadonna P.
PMID: 28293415
Clin Transl Allergy. 2017 Mar 13;7:7. doi: 10.1186/s13601-017-0144-0. eCollection 2017.

Drug hypersensitivity reactions (DHRs) affect an unknown proportion of the general population, and are an important public health problem due to their potential to cause life-threatening anaphylaxis and rare severe cutaneous allergic reactions. DHR evaluations are frequently needed in...

Cite
Torres MJ, Romano A, Celik G, et al. Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America. Clin Transl Allergy. 2017;7:7doi: 10.1186/s13601-017-0144-0.
Torres, M. J., Romano, A., Celik, G., Demoly, P., Khan, D. A., Macy, E., Park, M., Blumenthal, K., Aberer, W., Castells, M., Barbaud, A., Mayorga, C., & Bonadonna, P. (2017). Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America. Clinical and translational allergy, 77. https://doi.org/10.1186/s13601-017-0144-0
Torres, M J, et al. "Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America." Clinical and translational allergy vol. 7 (2017): 7. doi: https://doi.org/10.1186/s13601-017-0144-0
Torres MJ, Romano A, Celik G, Demoly P, Khan DA, Macy E, Park M, Blumenthal K, Aberer W, Castells M, Barbaud A, Mayorga C, Bonadonna P. Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America. Clin Transl Allergy. 2017 Mar 13;7:7. doi: 10.1186/s13601-017-0144-0. eCollection 2017. PMID: 28293415; PMCID: PMC5347172.
Copy Download .nbib Format: NLM
Protocolisation, Use and Development of Anti-Cancer Drugs in the Context of T2A (Case-Mix Based Payment System) Set-Up.

Therapie

Mathieu-Boué A, Demolis P, Bergmann JF.
PMID: 27393309
Therapie. 2006 Jul-Aug;61(4):309-12. doi: 10.2515/therapie:2006055.

Drugs used in oncology represent more than half of the innovative and costly drugs which are not covered by a Group Homogène de Soins (DRG type classification) within the context of the case-mix based payment system (termed T2A). For...

Cite
Mathieu-Boué A, Demolis P, Bergmann JF. Protocolisation, Use and Development of Anti-Cancer Drugs in the Context of T2A (Case-Mix Based Payment System) Set-Up. Therapie. 2006;61(4):309-12doi: 10.2515/therapie:2006055.
Mathieu-Boué, A., Demolis, P., Bergmann, J. F. (2006). Protocolisation, Use and Development of Anti-Cancer Drugs in the Context of T2A (Case-Mix Based Payment System) Set-Up. Therapie, 61(4), 309-12. https://doi.org/10.2515/therapie:2006055
Mathieu-Boué, Anne, et al. "Protocolisation, Use and Development of Anti-Cancer Drugs in the Context of T2A (Case-Mix Based Payment System) Set-Up." Therapie vol. 61,4 (2006): 309-12. doi: https://doi.org/10.2515/therapie:2006055
Mathieu-Boué A, Demolis P, Bergmann JF. Protocolisation, Use and Development of Anti-Cancer Drugs in the Context of T2A (Case-Mix Based Payment System) Set-Up. Therapie. 2006 Jul-Aug;61(4):309-12. doi: 10.2515/therapie:2006055. PMID: 27393309.
Copy Download .nbib Format: NLM
«Cognitus & Moi»: A Computer-Based Cognitive Remediation Program for Children with Intellectual Disability.

Frontiers in psychiatry

Demily C, Rigard C, Peyroux E, Chesnoy-Servanin G, Morel A, Franck N.
PMID: 26869942
Front Psychiatry. 2016 Feb 03;7:10. doi: 10.3389/fpsyt.2016.00010. eCollection 2016.

Attentional, visuospatial, and social cognition deficits have a negative impact on children's adaptative and social competences and, as a result, on their ability to achieve a normal functioning and behavior. Until now and despite the frequency of those deficits,...

Cite
Demily C, Rigard C, Peyroux E, et al. «Cognitus & Moi»: A Computer-Based Cognitive Remediation Program for Children with Intellectual Disability. Front Psychiatry. 2016;7:10doi: 10.3389/fpsyt.2016.00010.
Demily, C., Rigard, C., Peyroux, E., Chesnoy-Servanin, G., Morel, A., & Franck, N. (2016). «Cognitus & Moi»: A Computer-Based Cognitive Remediation Program for Children with Intellectual Disability. Frontiers in psychiatry, 710. https://doi.org/10.3389/fpsyt.2016.00010
Demily, Caroline, et al. "«Cognitus & Moi»: A Computer-Based Cognitive Remediation Program for Children with Intellectual Disability." Frontiers in psychiatry vol. 7 (2016): 10. doi: https://doi.org/10.3389/fpsyt.2016.00010
Demily C, Rigard C, Peyroux E, Chesnoy-Servanin G, Morel A, Franck N. «Cognitus & Moi»: A Computer-Based Cognitive Remediation Program for Children with Intellectual Disability. Front Psychiatry. 2016 Feb 03;7:10. doi: 10.3389/fpsyt.2016.00010. eCollection 2016. PMID: 26869942; PMCID: PMC4737901.
Copy Download .nbib Format: NLM
Psychiatric manifestations of treatable hereditary metabolic disorders in adults.

Annals of general psychiatry

Demily C, Sedel F, Prayitno BA, Maridi M.
PMID: 25478001
Ann Gen Psychiatry. 2014 Sep 24;13:27. doi: 10.1186/s12991-014-0027-x. eCollection 2014.

Detecting psychiatric disorders of secondary origin is a crucial concern for the psychiatrist. But how can this reliably be done among a large number of conditions, most of which have a very low prevalence? Metabolic screening undertaken in a...

Cite
Demily C, Sedel F, Prayitno BA, et al. Psychiatric manifestations of treatable hereditary metabolic disorders in adults. Ann Gen Psychiatry. 2014;13:27doi: 10.1186/s12991-014-0027-x.
Demily, C., Sedel, F., Prayitno, B. A., & Maridi, M. (2014). Psychiatric manifestations of treatable hereditary metabolic disorders in adults. Annals of general psychiatry, 1327. https://doi.org/10.1186/s12991-014-0027-x
Demily, Caroline, et al. "Psychiatric manifestations of treatable hereditary metabolic disorders in adults." Annals of general psychiatry vol. 13 (2014): 27. doi: https://doi.org/10.1186/s12991-014-0027-x
Demily C, Sedel F, Prayitno BA, Maridi M. Psychiatric manifestations of treatable hereditary metabolic disorders in adults. Ann Gen Psychiatry. 2014 Sep 24;13:27. doi: 10.1186/s12991-014-0027-x. eCollection 2014. PMID: 25478001; PMCID: PMC4255667.
Copy Download .nbib Format: NLM
Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose.

Clinical and translational allergy

Demoly P, Passalacqua G, Calderon MA, Yalaoui T.
PMID: 26702353
Clin Transl Allergy. 2015 Dec 23;5:44. doi: 10.1186/s13601-015-0088-1. eCollection 2015.

Sublingual immunotherapy (SLIT) is an effective and well-tolerated method of treating allergic respiratory diseases associated with seasonal and perennial allergens. In contrast to the subcutaneous route, SLIT requires a much greater amount of antigen to achieve a clinical effect....

Cite
Demoly P, Passalacqua G, Calderon MA, et al. Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose. Clin Transl Allergy. 2015;5:44doi: 10.1186/s13601-015-0088-1.
Demoly, P., Passalacqua, G., Calderon, M. A., & Yalaoui, T. (2015). Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose. Clinical and translational allergy, 544. https://doi.org/10.1186/s13601-015-0088-1
Demoly, Pascal, et al. "Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose." Clinical and translational allergy vol. 5 (2015): 44. doi: https://doi.org/10.1186/s13601-015-0088-1
Demoly P, Passalacqua G, Calderon MA, Yalaoui T. Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose. Clin Transl Allergy. 2015 Dec 23;5:44. doi: 10.1186/s13601-015-0088-1. eCollection 2015. PMID: 26702353; PMCID: PMC4689001.
Copy Download .nbib Format: NLM
A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress.

Clinical and translational allergy

Hellings PW, Muraro A, Fokkens W, Mullol J, Bachert C, Canonica GW, Price D, Papadopoulos N, Scadding G, Rasp G, Demoly P, Murray R, Bousquet J.
PMID: 26509001
Clin Transl Allergy. 2015 Oct 27;5:36. doi: 10.1186/s13601-015-0080-9. eCollection 2015.

BACKGROUND: The concept of control is gaining importance in the field of allergic rhinitis (AR), with a visual analogue scale (VAS) score being a validated, easy and attractive tool to evaluate AR symptom control. The doctors' perception of a...

Cite
Hellings PW, Muraro A, Fokkens W, et al. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clin Transl Allergy. 2015;5:36doi: 10.1186/s13601-015-0080-9.
Hellings, P. W., Muraro, A., Fokkens, W., Mullol, J., Bachert, C., Canonica, G. W., Price, D., Papadopoulos, N., Scadding, G., Rasp, G., Demoly, P., Murray, R., & Bousquet, J. (2015). A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clinical and translational allergy, 536. https://doi.org/10.1186/s13601-015-0080-9
Hellings, Peter W, et al. "A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress." Clinical and translational allergy vol. 5 (2015): 36. doi: https://doi.org/10.1186/s13601-015-0080-9
Hellings PW, Muraro A, Fokkens W, Mullol J, Bachert C, Canonica GW, Price D, Papadopoulos N, Scadding G, Rasp G, Demoly P, Murray R, Bousquet J. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clin Transl Allergy. 2015 Oct 27;5:36. doi: 10.1186/s13601-015-0080-9. eCollection 2015. PMID: 26509001; PMCID: PMC4621924.
Copy Download .nbib Format: NLM
Allergen immunotherapy for allergic asthma: protocol for a systematic review.

Clinical and translational allergy

Dhami S, Nurmatov U, Agache I, Lau S, Muraro A, Jutel M, Roberts G, Akdis C, Bonini M, Calderon M, Casale T, Cavkaytar O, Cox L, Demoly P, Flood B, Hamelmann E, Izuhara K, Kalayci Ö, Kleine-Tebbe J, Nieto A, Papadopoulos N, Pfaar O, Rosenwasser L, Ryan D, Schmidt-Weber C, Szefler S, Wahn U, van Wijk RG, Wilkinson J, Sheikh A.
PMID: 26862389
Clin Transl Allergy. 2016 Feb 09;6:5. doi: 10.1186/s13601-016-0094-y. eCollection 2015.

BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for Allergic Asthma. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in...

Cite
Dhami S, Nurmatov U, Agache I, et al. Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clin Transl Allergy. 2016;6:5doi: 10.1186/s13601-016-0094-y.
Dhami, S., Nurmatov, U., Agache, I., Lau, S., Muraro, A., Jutel, M., Roberts, G., Akdis, C., Bonini, M., Calderon, M., Casale, T., Cavkaytar, O., Cox, L., Demoly, P., Flood, B., Hamelmann, E., Izuhara, K., Kalayci, �. �., Kleine-Tebbe, J., Nieto, A., Papadopoulos, N., Pfaar, O., Rosenwasser, L., Ryan, D., Schmidt-Weber, C., Szefler, S., Wahn, U., van Wijk, R. G., Wilkinson, J., & Sheikh, A. (2015). Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clinical and translational allergy, 65. https://doi.org/10.1186/s13601-016-0094-y
Dhami, Sangeeta, et al. "Allergen immunotherapy for allergic asthma: protocol for a systematic review." Clinical and translational allergy vol. 6 (2015): 5. doi: https://doi.org/10.1186/s13601-016-0094-y
Dhami S, Nurmatov U, Agache I, Lau S, Muraro A, Jutel M, Roberts G, Akdis C, Bonini M, Calderon M, Casale T, Cavkaytar O, Cox L, Demoly P, Flood B, Hamelmann E, Izuhara K, Kalayci Ö, Kleine-Tebbe J, Nieto A, Papadopoulos N, Pfaar O, Rosenwasser L, Ryan D, Schmidt-Weber C, Szefler S, Wahn U, van Wijk RG, Wilkinson J, Sheikh A. Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clin Transl Allergy. 2016 Feb 09;6:5. doi: 10.1186/s13601-016-0094-y. eCollection 2015. PMID: 26862389; PMCID: PMC4746770.
Copy Download .nbib Format: NLM
Anti-K1 (Kell) Antibody Expressed in Maternal Breastmilk: A Case Report of a Neonate with Multiple Intrauterine Transfusions and Postnatal Exposure to Kell Antibody in Maternal Breastmilk.

Case reports in pediatrics

DeMoss P, Asfour M, Hersey K.
PMID: 28357148
Case Rep Pediatr. 2017;2017:6927813. doi: 10.1155/2017/6927813. Epub 2017 Mar 05.

Hemolytic disease of the fetus and newborn is a common consideration in newborn medicine, especially among the jaundiced. Maternal breastmilk provides numerous benefits to the infant, including nutrition and immunologic factors. Here, we present an infant who received three...

Cite
DeMoss P, Asfour M, Hersey K. Anti-K1 (Kell) Antibody Expressed in Maternal Breastmilk: A Case Report of a Neonate with Multiple Intrauterine Transfusions and Postnatal Exposure to Kell Antibody in Maternal Breastmilk. Case Rep Pediatr. 2017;2017:6927813doi: 10.1155/2017/6927813.
DeMoss, P., Asfour, M., & Hersey, K. (2017). Anti-K1 (Kell) Antibody Expressed in Maternal Breastmilk: A Case Report of a Neonate with Multiple Intrauterine Transfusions and Postnatal Exposure to Kell Antibody in Maternal Breastmilk. Case reports in pediatrics, 20176927813. https://doi.org/10.1155/2017/6927813
DeMoss, Patrick, et al. "Anti-K1 (Kell) Antibody Expressed in Maternal Breastmilk: A Case Report of a Neonate with Multiple Intrauterine Transfusions and Postnatal Exposure to Kell Antibody in Maternal Breastmilk." Case reports in pediatrics vol. 2017 (2017): 6927813. doi: https://doi.org/10.1155/2017/6927813
DeMoss P, Asfour M, Hersey K. Anti-K1 (Kell) Antibody Expressed in Maternal Breastmilk: A Case Report of a Neonate with Multiple Intrauterine Transfusions and Postnatal Exposure to Kell Antibody in Maternal Breastmilk. Case Rep Pediatr. 2017;2017:6927813. doi: 10.1155/2017/6927813. Epub 2017 Mar 05. PMID: 28357148; PMCID: PMC5357519.
Copy Download .nbib Format: NLM
Transcript abundance on its own cannot be used to infer fluxes in central metabolism.

Frontiers in plant science

Schwender J, König C, Klapperstück M, Heinzel N, Munz E, Hebbelmann I, Hay JO, Denolf P, De Bodt S, Redestig H, Caestecker E, Jakob PM, Borisjuk L, Rolletschek H.
PMID: 25506350
Front Plant Sci. 2014 Nov 28;5:668. doi: 10.3389/fpls.2014.00668. eCollection 2014.

An attempt has been made to define the extent to which metabolic flux in central plant metabolism is reflected by changes in the transcriptome and metabolome, based on an analysis of in vitro cultured immature embryos of two oilseed...

Cite
Schwender J, König C, Klapperstück M, et al. Transcript abundance on its own cannot be used to infer fluxes in central metabolism. Front Plant Sci. 2014;5:668doi: 10.3389/fpls.2014.00668.
Schwender, J., König, C., Klapperstück, M., Heinzel, N., Munz, E., Hebbelmann, I., Hay, J. O., Denolf, P., De Bodt, S., Redestig, H., Caestecker, E., Jakob, P. M., Borisjuk, L., & Rolletschek, H. (2014). Transcript abundance on its own cannot be used to infer fluxes in central metabolism. Frontiers in plant science, 5668. https://doi.org/10.3389/fpls.2014.00668
Schwender, Jörg, et al. "Transcript abundance on its own cannot be used to infer fluxes in central metabolism." Frontiers in plant science vol. 5 (2014): 668. doi: https://doi.org/10.3389/fpls.2014.00668
Schwender J, König C, Klapperstück M, Heinzel N, Munz E, Hebbelmann I, Hay JO, Denolf P, De Bodt S, Redestig H, Caestecker E, Jakob PM, Borisjuk L, Rolletschek H. Transcript abundance on its own cannot be used to infer fluxes in central metabolism. Front Plant Sci. 2014 Nov 28;5:668. doi: 10.3389/fpls.2014.00668. eCollection 2014. PMID: 25506350; PMCID: PMC4246676.
Copy Download .nbib Format: NLM
Prospects for a vaccine in allergic diseases and asthma.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Bousquet J, Yssel H, Demoly P.
PMID: 18034513
BioDrugs. 2000 Jan;13(1):61-75. doi: 10.2165/00063030-200013010-00006.

Allergen-specific immunotherapy is widely used to treat allergic diseases, and current research is now focusing on the development of therapeutic vaccines acting on the IgE immune response following allergen challenge. The IgE immune response is dependent on genetic and...

Cite
Bousquet J, Yssel H, Demoly P. Prospects for a vaccine in allergic diseases and asthma. BioDrugs. 2000;13(1):61-75doi: 10.2165/00063030-200013010-00006.
Bousquet, J., Yssel, H., & Demoly, P. (2000). Prospects for a vaccine in allergic diseases and asthma. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 13(1), 61-75. https://doi.org/10.2165/00063030-200013010-00006
Bousquet, J, et al. "Prospects for a vaccine in allergic diseases and asthma." BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 13,1 (2000): 61-75. doi: https://doi.org/10.2165/00063030-200013010-00006
Bousquet J, Yssel H, Demoly P. Prospects for a vaccine in allergic diseases and asthma. BioDrugs. 2000 Jan;13(1):61-75. doi: 10.2165/00063030-200013010-00006. PMID: 18034513.
Copy Download .nbib Format: NLM
Stereospecific and stereodivergent construction of quaternary carbon centers through switchable directed/nondirected allylic substitution.

Angewandte Chemie (International ed. in English)

Breit B, Demel P, Studte C.
PMID: 15258936
Angew Chem Int Ed Engl. 2004 Jul 19;43(29):3786-9. doi: 10.1002/anie.200453991.

No abstract available.

Cite
Breit B, Demel P, Studte C. Stereospecific and stereodivergent construction of quaternary carbon centers through switchable directed/nondirected allylic substitution. Angew Chem Int Ed Engl. 2004;43(29):3786-9doi: 10.1002/anie.200453991.
Breit, B., Demel, P., & Studte, C. (2004). Stereospecific and stereodivergent construction of quaternary carbon centers through switchable directed/nondirected allylic substitution. Angewandte Chemie (International ed. in English), 43(29), 3786-9. https://doi.org/10.1002/anie.200453991
Breit, Bernhard, et al. "Stereospecific and stereodivergent construction of quaternary carbon centers through switchable directed/nondirected allylic substitution." Angewandte Chemie (International ed. in English) vol. 43,29 (2004): 3786-9. doi: https://doi.org/10.1002/anie.200453991
Breit B, Demel P, Studte C. Stereospecific and stereodivergent construction of quaternary carbon centers through switchable directed/nondirected allylic substitution. Angew Chem Int Ed Engl. 2004 Jul 19;43(29):3786-9. doi: 10.1002/anie.200453991. PMID: 15258936.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 280 entries